Effective cancer vaccines targeted against specific antigens have eluded researchers for decades. When combined with a drug, one such vaccine now shrinks tumors in a mouse model of promyelocytic leukemia (pages 1413–1417).
This is a preview of subscription content, log in via an institution to check access.
References
Fisher, R.I., Rosenberg, S.A., Sznol, M., Parkinson, D.R. & Fyfe, G. Cancer J. Sci. Am. 3, 568–569 (1997).
Padua, R.A. et al. Nat. Med. 9, 1413–1417 (2003).
Small, E.J. et al. J. Clin. Oncol. 18, 3894–3903 (2000).
Dummer, R. Curr. Opin. Invest. Drugs 2, 844–888 (2001).
Belli, F. et al. J. Clin. Oncol. 20, 4169–4180 (2002).
Su, Z. et al. Cancer Res. 63, 2127–2133 (2003).
O'Rourke, M.G. et al. Cancer Immunol. Immunother. 52, 387–395 (2003).
Peterson, A.C., Harlin, H. & Gajewski, T.F. J. Clin. Oncol. 21, 2342–2348 (2003).
Sheets, E.E. et al. Am. J. Obstet. Gynecol. 188, 916–926 (2003).
Park, D.J., Vuong, P.T., DeVos, S., Douer, D. & Koeffler, H.P. Blood, published online 31 July 2003 (doi:10.1182/blood-2003-02-0412).
Westervelt, P. et al. Proc. Natl. Acad. Sci. USA 99, 9468–9473 (2002).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Donnelly, J. Cancer vaccine targets leukemia. Nat Med 9, 1354–1355 (2003). https://doi.org/10.1038/nm1103-1354
Issue Date:
DOI: https://doi.org/10.1038/nm1103-1354
- Springer Nature America, Inc.